Home
Faculty
Podcasts
Webcasts
FAQ Video Module
Journal Club Videos Module
Medical Review Videos Module
Publications
Digital Sponsors
Subscribe
X
Full Name
Email Address
Provider Type
Select Category
MD
DO
PA
NP
RN
MA
Dietician
Other
This field is required.
Subscribe
Reset
FAQ Video Modules
FAQ Video Modules
Category
Gastroenterology
Hepatology
General
Biosimilars
Sort by
Oldest
Newest
FAQ: What Is the Significance of Alarm Symptoms Including Pathophysiology?
APP Insight: Provide Diagnostic Tips for IBS-C
Using the Bristol Stool Scale to Measure Response to Treatment
FAQ: What Are the Main Causes of IBS, and How Does the Disease Progress Over Time?
What Are the Most Critical Updates in Cirrhosis Research That Clinicians Should Be Aware Of?
How Can Healthcare Professionals Improve Patient Outcomes in Those with Cirrhosis?
How Does the Guselkumab Data Align With the STRIDE II Guidelines?
KOL Interview: Can You Discuss Any Recent Breakthroughs in the Management of Cirrhosis?
What Should Patients Know About Living With Cirrhosis?
What Are Predictive Risk Factors for Disease Severity in CD and UC?
What Lifestyle Changes Are Essential for Managing Cirrhosis Effectively?
How Can You Support a Shared Decision Making Process With the Patient?
How Can Physicians Better Care for Patients With Cirrhosis?
Is There a Correlation Between Myeloid Cells Expressing CD64 and Endoscopic Disease Severity?
Why Is Binding CD64+ Important When Discussing IL-23 Directed Therapy?
Provide Immunologic Rationale for IL-23 Directed Therapy in IBD
What Is the Role of the IL-23/IL-17 Axis in IBD?
Describe the IL-23/IL-17 Axis
Define, Compare, and Contrast Humoral and Cell-Mediated Immunity
How Is MASH Severity Staged? What Would an Ideal MASH NIT Algorithm Look Like?
Download the app and start using it now
Download on the
App Store
GET IT ON
Google Play
X
Install our app for the best experience!
Install Now